Community-based misoprostol for the prevention of post-partum haemorrhage: A narrative review of the evidence base, challenges and scale-up

Abstract: 

Achieving Sustainable Development Goal targets for 2030 will requirepersistent investment and creativity in improving access to quality healthservices, including skilled attendance at birth and access to emergencyobstetric care. Community-based misoprostol has been extensivelystudied and recently endorsed by the WHO for the prevention of post-partum haemorrhage. There remains little consolidated information aboutexperience with implementation and scale-up to date. This narrativereview of the literature aimed to identify the political processes leading toWHO endorsement of misoprostol for the prevention of post-partumhaemorrhage and describe ongoing challenges to the uptake and scale-up at both policy and community levels. We review the peer-reviewedand grey literature on expansion and scale-up and present the issuescentral to moving forward.

Please click here to read the full article.

Author: 
Karen Hobday
Jennifer Hulme
Suzanne Belton
Caroline SE Homer
Ndola Prata
Jennifer Hulme
Publication date: 
March 30, 2017
Publication type: 
Journal Article
Citation: 
To cite this article: Karen Hobday, Jennifer Hulme, Suzanne Belton, Caroline SE Homer & Ndola Prata (2018) Community-based misoprostol for the prevention of post-partum haemorrhage: A narrative review of the evidence base, challenges and scale-up, Global Public Health, 13:8, 1081-1097, DOI: 10.1080/17441692.2017.1303743